A detailed history of Menlo Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Menlo Advisors LLC holds 69,231 shares of ABT stock, worth $7.91 Million. This represents 4.06% of its overall portfolio holdings.

Number of Shares
69,231
Previous 69,492 0.38%
Holding current value
$7.91 Million
Previous $7.22 Million 9.32%
% of portfolio
4.06%
Previous 4.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$100.07 - $118.13 $26,118 - $30,831
-261 Reduced 0.38%
69,231 $7.89 Million
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $9,569 - $10,681
-95 Reduced 0.14%
69,492 $7.22 Million
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $39,974 - $44,150
-365 Reduced 0.52%
69,587 $7.91 Million
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $1.56 Million - $1.87 Million
16,355 Added 30.51%
69,952 $6.77 Million
Q2 2023

Aug 15, 2023

SELL
$100.78 - $112.29 $90,702 - $101,061
-900 Reduced 1.65%
53,597 $5.84 Million
Q1 2023

Apr 12, 2023

SELL
$96.86 - $114.01 $29,058 - $34,203
-300 Reduced 0.55%
54,497 $5.52 Million
Q3 2022

Nov 15, 2022

BUY
$96.76 - $112.03 $2.42 Million - $2.8 Million
25,003 Added 83.92%
54,797 $5.3 Million
Q2 2022

Jul 20, 2022

BUY
$102.07 - $123.37 $33,172 - $40,095
325 Added 1.1%
29,794 $3.24 Million
Q4 2021

Feb 16, 2022

SELL
$115.53 - $141.46 $231,060 - $282,920
-2,000 Reduced 6.36%
29,469 $4.15 Million
Q2 2021

Aug 30, 2021

SELL
$105.79 - $124.53 $368,572 - $433,862
-3,484 Reduced 9.97%
31,469 $3.65 Million
Q1 2021

Apr 13, 2021

SELL
$108.84 - $128.23 $108 - $128
-1 Reduced -0.0%
34,953 $4.19 Million
Q2 2020

Jul 17, 2020

SELL
$76.57 - $98.0 $9,188 - $11,760
-120 Reduced 0.34%
34,954 $3.2 Million
Q1 2020

Apr 13, 2020

SELL
$62.82 - $91.86 $179,037 - $261,801
-2,850 Reduced 7.52%
35,074 $2.77 Million
Q3 2019

Oct 08, 2019

SELL
$81.84 - $88.74 $45,748 - $49,605
-559 Reduced 1.45%
37,924 $3.17 Million
Q2 2019

Jul 17, 2019

SELL
$72.88 - $85.0 $7,288 - $8,500
-100 Reduced 0.26%
38,483 $3.24 Million
Q1 2019

Apr 10, 2019

SELL
$66.22 - $80.06 $16,886 - $20,415
-255 Reduced 0.66%
38,583 $3.08 Million
Q4 2018

Jan 09, 2019

SELL
$65.56 - $74.27 $191,435 - $216,868
-2,920 Reduced 6.99%
38,838 $2.81 Million
Q3 2018

Oct 10, 2018

SELL
$60.81 - $73.36 $48,952 - $59,054
-805 Reduced 1.89%
41,758 $3.06 Million
Q2 2018

Jul 11, 2018

SELL
$57.57 - $63.54 $99,883 - $110,241
-1,735 Reduced 3.92%
42,563 $2.6 Million
Q1 2018

Apr 11, 2018

SELL
$56.27 - $63.62 $28,135 - $31,810
-500 Reduced 1.12%
44,298 $2.65 Million
Q4 2017

Jan 09, 2018

SELL
$53.68 - $57.47 $5,368 - $5,747
-100 Reduced 0.22%
44,798 $2.56 Million
Q3 2017

Oct 13, 2017

BUY
$48.06 - $53.64 $2.16 Million - $2.41 Million
44,898
44,898 $2.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Menlo Advisors LLC Portfolio

Follow Menlo Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menlo Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menlo Advisors LLC with notifications on news.